Abstract
Molecular farming provides a powerful tool for low cost production of recombinant proteins with pharmaceutical value. The use of transgenic plants has been increasingly tested as alternative system for obtaining biologically active human lactoferrin in plants. Precise selection of plant species, transformation techniques and expression cassettes, in addition to conduction of detailed glycosylation and immunogenicity studies, serves as basis of obtaining safe recombinant human lactoferrin in high concentrations for the use of pharmacy. On the other hand, expression of antimicrobial protein lactoferrin in plants is a promising opportunity for crop quality improvement by increasing plant disease resistance.
Similar content being viewed by others
Abbreviations
- Lf:
-
lactoferrin
References
Anzai, H., Takaiwa, F., Katsumata, K.: Production of human lactoferrin in transgenic plants.-In: Shimazaki, K., Tsuda, H., Tomita, M., Kuwata, T., Perraudin, J.-P. (ed.): Lactoferrin: Structure, Function and Applications. Pp. 265–271. Elsevier, Amsterdam 2000.
Arakawa, T., Chong, D.K.X., Langridge, W.H.R.: Efficacy of a food plant based oral cholera toxin B subunit vaccine.-Nature Biotechnol. 16: 292–297, 1998.
Bardor, M., Faveeuw, C., Fitchette, A.-C., Gilbert, D., Galas, L., Trottein, F., Faye, L., Lerouge P.: Immunoreactivity in mammals of two typical plant glyco-epitopes, core α(1,3)-fucose and core xylose.-Glycobiology 13: 427–434, 2003.
Bardor, M., Loutelier-Bourhis, C., Paccalet, T., Cosette, P., Fitchette, A.-C., Vézina, L.-P., Trépanier, S., Dargis, M., Lemieux, R., Lange, C., Faye, L., Lerouge, P.: Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glycol-engineering into human-compatible structures.-Plant Biotechnol. J. 1: 451–462, 2003.
Bříza, J., Pavingerová, D., Vlasák J., Ludvíková, V., Niedermeierová, H.: Production of human papillomavirus type 16 E7 oncoprotein fused with β-glucuronidase in transgenic tomato and potato plants.-Biol. Plant. 51: 268–276, 2007.
Busse, U., Levée, V., Trépanier, S., Vézina, L.-P.: Production of antibodies in alfalfa (Medicago sativa).-In: Erickson L. (ed.): Molecular Farming of Plants and Animal for Human and Veterinary Medicine. Pp. 199–219. J. Wiley & Sons, New York 2001.
Chen, M., Liu, X., Wang, Z., Song, J., Qi, Q., Wang, P.G.: Modification of Plant N-glycans processing: the future of producing therapeutic protein by transgenic plants.-Med. Res. Rev. 25: 343–360, 2005.
Choi, S.-M., Lee, O.-S., Kwon, S.-Y., Kwak, S.-S., Yu, D.-Y., Lee, H.-S.: High expression of a human lactoferrin in transgenic tobacco cell cultures.-Biotechnol. Lett. 25: 213–218, 2003.
Chong, D.K.X., Langridge, W.H.R.: Expression of full-length bioactive antimicrobal human lactoferrin in potato plants.-Transgenic Res. 9: 71–78, 2000.
D’Aoust, M.-A., Lerouge, P., Busse, U., Bilodeau, P., Trépanier, S., Gomord, V., Faye, L., Vézina, L-P.: Efficient and reliable production of pharmaceuticals in alfalfa.-In: Fischer, R., Schillberg, S. (ed.): Molecular Farming. Pp. 1–12. Wiley-VCH-Verlag, Weinheim 2004.
Damiens, E., Mazurier, J., El Yazidi, I., Masson, M., Duthille, I., Spik, G., Boilly-Marer, Y.: Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumor cells.-Biochim. biophys. Acta 1402: 277–287, 1998.
Fischer, R., Emans, N., Schuster, F., Hellwig, S., Drossard, J.: Towards molecular farming in the future: using plant cell-suspension cultures as bioreactor.-Biotechnol. appl. Biochem. 30: 109–112, 1999.
Fischer, R., Stoger, E., Schillberg, S., Christou, P., Twyman, R.M.: Plant-based productions of biopharmaceuticals.-Curr. Opin. Plant Biol. 7: 152–158, 2004.
Hendrixson, D.R., Qiu, J., Shewry, S.C., Fink, D.L., Petty, S., Baker, E.N., Plaut, A.G., Geme III, J.W.St.: Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites.-Mol. Microbiol. 47: 607–617, 2003.
Horn, M.E., Woodard, S.L., Howard, J.A.: Plant molecular farming: systems and products.-Plant Cell Rep. 22: 711–720, 2004.
Kamenarova, K., Gecheff, K., Stoyanova, M., Muhovski, Y., Anzai, H., Atanassov, A.: Production of recombinant human lactoferrin in transgenic barley.-Biotechnol. Biotechnol. Eq. 21: 18–27, 2007.
Kanyshkova, T.G., Babina, S.E., Semenov, D.V., Isaeva, N., Vlassov, A.V., Neustroev, K.N., Kul’minskaya, A.A., Buneva, V.N., Nevinsky, G.A.: Multiple enzymic activities of human milk lactoferrin.-Eur. J. Biochem. 270: 3353–3361, 2003.
Kawakami, H., Lönnerdal, B.: Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes.-Amer. J. Physiol. 261: G841–G846, 1991.
Krimpenfort, P.: The production of human lactoferrin in the milk of transgenic animals.-Cancer Detect Prev. 17: 301–305, 1993.
Kwon, S.Y., Jo, S.H., Lee, O.S., Choi, S.M., Kwak, S.S., Lee, H.S.: Transgenic ginseng cell lines that produse high levels of a human lactoferrin.-Planta med. 69: 1005–1008, 2003.
Lee, T.-J., Coyne, P.P., Clemente, T.E., Mitra, A.: Partial resistance to bacterial wilt in transgenic tomato plants expressing antibacterial Lactoferrin gene.-J. amer. Soc. hort. Sci. 127: 158–168, 2002.
Liang, Q., Richardson, T.: Expression and characterization of human lactoferrin in yeast Saccharomyces cerevisiae.-J. Agr. Food Chem. 41: 1800–1807, 1993.
Liu, J.R., Lee, M.H., Lee, S.H., Yu, D.-Y., Lee, K.-K., Chung, W.-I.: Expression of human lactoferrin gene in transgenic tobacco plants: feasibility of virus resistance.-In: Proceedings of the 1st Japan Korea Joint Seminar on the Production of Recombinant Proteins and Transgenic Animals in Present and Future. Pp. 39–45. 1996.
Liu, T., Zhang, Y.-Z., Wu, X.-F.: High level expression of functionally active human lactoferrin in silkworm larvae.-J. Biotechnol. 118: 246–256, 2005.
Lönnerdal, B.: Expression of human milk proteins in plants.-J. amer. Coll. Nutr. 21: 218S–221S, 2002.
Mason, H.S., Lam, D.M.K., Arntzen, C.J.: Expression ot hepatitis B surface antigen in transgenic plants.-Proc. nat. Acad. Sci. USA 89: 11745–11749, 1992.
Min, S.R., Woo, J.W., Jeong, W.J., Han, S.K., Lee, Y.B., Liu, J.R.: Production of human lactoferrin in transgenic cell suspension cultures of sweet potato.-Biol. Plant. 50: 131–134, 2006.
Mitra, A., Zhang, Z.: Expression of a human lactoferrin cDNA in tobacco cells produces antibacterial protein(s).-Plant Physiol. 106: 977–981, 1994.
Nandi, S., Suzuki, Y.A., Huang, J., Yalda, D., Pham, P., Wu, L., Bartley, G., Huang, N., Lönnerdal, B.: Expression of human lactoferrin in transgenic rice grains for the application in infant formula.-Plant Sci. 163: 713–722, 2002.
Naot, D., Grey, A., Reid, I.R., Cornish, J.: Lactoferrin — A novel bone growth factor.-Clin. med. Res. 3: 93–101, 2005.
Nuijens, J.H., Van Berkel, P.H., Geerts, M.E., Hartevelt, P.P., De Boer, H.A., Van Veen, H.A., Pieper, F.R.: Characterization of recombinant human lactoferrin secreted in milk of transgenic mice.-J. biol. Chem. 272: 8802–8807, 1997.
Platenburg, G.J., Kootwijk, E.P., Kooiman, P.M., Woloshuk, S.L., Nuijens, J.H., Krimpenfort, P.J., Pieper, F.R., De Boer, H.A., Strijker, R.: Expressiom of human lactoferrin in milk of transgenic mice.-Transgenic Res. 3: 99–108, 1994.
Salmon, V., Legrand, D., Slomianny, M.-C., Yazidi, I.E., Spik, G., Gruber, V., Bournat, P., Olagnier, B., Mison, D., Theisen, M., Mérot, B.: Production of human lactoferrin in transgenic tobacco plants.-Protein Exp. Purif. 13: 127–135, 1998.
Samyn-Petit, B., Dubos, J.-P.W., Chirat, F., Coddeville, B., Demaizieres, G., Farrer, S., Slomianny, M.-C., Theisen, M., Delannoy, P.: Comparative analysis of the site-specific N-glycosylation of human lactoferrin produced in maize and tobacco plants.-Eur. J. Biochem. 270: 3235–3242, 2003.
Samyn-Petit, B., Gruber, V., Flahaut, C., Wajda-Dubos, J.-P., Farrer, S., Pons, A., Desmaizieres, G., Slomianny, M.-C., Theisen, M., Delannoy, P.: N-glycosylation potential of maize: the human lactoferrin used as a model.-Glycoconjucate J. 18: 519–527, 2001.
Spik, G., Theisen, M.: Characterization of the post-translational biochemical processing of human lactoferrin expressed in transgenic tobacco.-Bundesgesundheitsblatt-Gesundheitsforsch-Gesundheitsschutz 43: 104–109, 2000.
Stoger, E., Ma, J.K.-C., Fischer, R., Christou, P.: Sowing the seeds of success: pharmaceutical proteins from plants.-Current Opin. Biotechnol. 16: 167–173, 2005.
Stowell, K.M., Rado, T.A., Funk, W.D., Tweedie, J.W.: Expression of cloned human lactoferrin in baby-hamster kidney cells.-Biochem. J. 276: 349–355, 1991.
Sunil Kumar, G.B., Ganapathi, T.R., Srinivas, L., Revathi, C.J., Bapat, V.A.: Hepatitis B surface antigen expression in NT-1 cells of tobacco using different expression cassettes.-Biol. Plant. 51: 467–471, 2007.
Takase, K., Hagiwara, K., Onodera, H., Nishizawa, Y., Ugaki, M., Omura, T., Numata, S., Akutsu, K., Kumura, H., Shimazaki, K.: Constitutive expression of human lactoferrin and its N-lobe in rice plants to confer disease resistance.-Biochem. Cell Biol. 83: 239–249, 2005.
Twyman, R.M., Stoger, E., Schillberg, S., Christou, P., Fischer, R.: Molecular pharming in plants: host systems and expression technology.-Trends Biotechnol. 21: 570–577, 2003.
Van Berkel, P.H., Geerts, M.E., Van Veen, H.A., Kooiman, P.M., Pieper, F.R., De Boer, H.A., Nuijens, J.H.: Glycosylated and unglycosylated human lactoferrin both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards tryptic proteolysis.-Biochem. J. 312: 107–114, 1995.
Van Berkel, P.H., Nuijens, J.H., Van Veen, H.A., Abrahams, J.P., Thomassen, E.A.J. The protein structure of recombinant human lactoferrin produced in the milk of transgenic cows closely matches the structure of human milk-derived lactoferrin.-Transgenic Res. 14: 397–405, 2005.
Van der Strate, B.W.A., Beljaars, L., Molema, G., Harmsen, M.C., Meijer, D.K.F.: Antiviral activities of lactoferrin.-Antiviral Res. 52: 225–239, 2001.
Ward, P.P., Lo, J.Y., Duke, M., May, G.S., Headon, D.R., Conneely, O.M.: Production of biologically active recombinant human lactoferrin in Aspergillus orizae.-Bio/Technology 10: 784–789, 1992.
Ward, P.P., Piddington, C.S., Cunningham, G.A., Zhou, X., Wyatt, R.D., Conneely, O.M.: A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic.-Biotechnology 13: 498–503, 1995.
Yamauchi, K., Tomita, M., Giehl, T.J., Ellison, R.T.: Antibacterial activity of lactoferrin and a pepsin derived lactoferrine peptide fragment.-Infect. Immun. 61: 719–728, 1993.
Zhang, Z., Coyne, D.P., Vidaver, A.K., Mitra, A.: Expression of human lactoferrin cDNA confers resistance to Ralstonia solanacearum in transgenic tobacco plants.-Phytopathology 88: 730–734, 1998.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stefanova, G., Vlahova, M. & Atanassov, A. Production of recombinant human lactoferrin from transgenic plants. Biol Plant 52, 423–428 (2008). https://doi.org/10.1007/s10535-008-0086-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10535-008-0086-4